News Releases Investor Relations Investor Menu Overview Events & Presentations Upcoming Events Past Events Presentations Stock Info Stock Quote & Chart Historic Price Lookup Investment Calculator News Releases SEC Filings Analyst Coverage Governance Documents & Charters Committee Composition IR Resources Investor FAQs Email Alerts Contact IR News Releases Year: All News201920182017 Summary ToggleDova Pharmaceuticals Announces Four Presentations at the 59th American Society of Hematology Annual Meeting December 4, 2017 View News Release > Summary ToggleDova Pharmaceuticals Announces FDA Acceptance of the Avatrombopag New Drug Application (NDA) with Priority Review November 27, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Present at Evercore ISI Conference November 21, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Present at Jefferies 2017 London Healthcare Conference November 10, 2017 View News Release > Summary ToggleDova Pharmaceuticals Reports Third Quarter 2017 Operating and Financial Results November 9, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Announce Third Quarter 2017 Financial Results on November 9, 2017 November 2, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Present Phase 3 Avatrombopag Data at the 2017 Liver Meeting of the American Association for the Study of Liver Diseases (AASLD) October 10, 2017 View News Release > Summary ToggleDova Pharmaceuticals Announces New Drug Application Submission to FDA for Avatrombopag, a Second Generation Thrombopoietin Receptor Agonist September 22, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Present at 2017 Leerink Partners Rare Disease Roundtable September 20, 2017 View News Release > Summary ToggleDova Pharmaceuticals Reports Second Quarter 2017 Operating and Financial Results August 10, 2017 View News Release > Pagination First page First Previous page Previous … Page 2 Page 3 Current page 4 Page 5 Next page Next Last page Last
News Releases Year: All News201920182017 Summary ToggleDova Pharmaceuticals Announces Four Presentations at the 59th American Society of Hematology Annual Meeting December 4, 2017 View News Release > Summary ToggleDova Pharmaceuticals Announces FDA Acceptance of the Avatrombopag New Drug Application (NDA) with Priority Review November 27, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Present at Evercore ISI Conference November 21, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Present at Jefferies 2017 London Healthcare Conference November 10, 2017 View News Release > Summary ToggleDova Pharmaceuticals Reports Third Quarter 2017 Operating and Financial Results November 9, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Announce Third Quarter 2017 Financial Results on November 9, 2017 November 2, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Present Phase 3 Avatrombopag Data at the 2017 Liver Meeting of the American Association for the Study of Liver Diseases (AASLD) October 10, 2017 View News Release > Summary ToggleDova Pharmaceuticals Announces New Drug Application Submission to FDA for Avatrombopag, a Second Generation Thrombopoietin Receptor Agonist September 22, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Present at 2017 Leerink Partners Rare Disease Roundtable September 20, 2017 View News Release > Summary ToggleDova Pharmaceuticals Reports Second Quarter 2017 Operating and Financial Results August 10, 2017 View News Release > Pagination First page First Previous page Previous … Page 2 Page 3 Current page 4 Page 5 Next page Next Last page Last
